Vascular endothelial growth factor (VEGF) is overproduced, which promotes vascular permeability and neovascularisation, in patients with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome1,2. Here, VEGFA is linked to endocrine system disorder.